Tandem Diabetes Care (TNDM) Operating Income (2013 - 2026)
Tandem Diabetes Care (TNDM) posted Operating Income of -$17.4 million for Q1 2026, down 310.2% on a QoQ basis from $8.3 million in Q4 2025, and up 85.58% year-over-year from -$9.4 million in Q1 2025.
Tandem Diabetes Care (TNDM) Operating Income (2013 - 2026) Analysis & Trends
Tandem Diabetes Care's Operating Income history runs 14 years deep, the most recent figure standing at -$17.4 million for Q1 2026.
- Quarterly Operating Income rose 85.58% year-over-year to -$17.4 million in Q1 2026, while the trailing twelve-month figure through Mar 2026 was -$83.8 million (up 53.0% YoY) and the FY2025 annual result came in at -$187.3 million, down 88.91% from the prior year.
- Operating Income was -$17.4 million for Q1 2026 at Tandem Diabetes Care, down from $8.3 million in the prior quarter.
- Across five years, Operating Income topped out at $8.3 million in Q4 2025 and bottomed at -$127.8 million in Q1 2023.
- A 5-year average of -$37.1 million and a median of -$30.8 million in 2024 frame the typical range for Operating Income.
- Annual changes were most pronounced in 2023 — Operating Income plunged 733.34% — and 2025, when it soared 1527.54%.
- Tandem Diabetes Care's Operating Income stood at -$17.8 million in 2022, then slumped by 97.22% to -$35.1 million in 2023, then jumped by 98.34% to -$581000.0 in 2024, then surged by 1527.54% to $8.3 million in 2025, then sank by 310.2% to -$17.4 million in 2026.
- Business Quant data shows TNDM's Operating Income at -$17.4 million in Q1 2026, $8.3 million in Q4 2025, and -$22.9 million in Q3 2025.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Op. Inc (Qtr) |
|---|---|---|---|---|---|
| 1 | Abbott Laboratories | 201.40 Bn | 194.75 Bn | 6.27 Bn | 1.35 Bn |
| 2 | Stryker | 122.29 Bn | 119.41 Bn | 3.81 Bn | 936.00 Mn |
| 3 | Medtronic | 105.01 Bn | 96.40 Bn | 6.41 Bn | 1.87 Bn |
| 4 | Boston Scientific | 64.81 Bn | 63.59 Bn | 3.61 Bn | 1.10 Bn |
| 5 | Edwards Lifesciences | 55.28 Bn | 51.60 Bn | 1.29 Bn | 477.60 Mn |
| 6 | Dexcom | 29.06 Bn | 27.94 Bn | 750.30 Mn | 255.30 Mn |
| 7 | Koninklijke Philips | 29.02 Bn | 25.93 Bn | 2.07 Bn | 282.15 Mn |
| 8 | GE HealthCare Technologies | 28.27 Bn | 26.20 Bn | 1.98 Bn | 515.00 Mn |
| 9 | Smith & Nephew | 25.80 Bn | 25.22 Bn | - | - |
| 10 | Tandem Diabetes Care | 1.16 Bn | 587.46 Mn | 136.79 Mn | -17.43 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | -17.43 Mn |
| Dec 31, 2025 | 8.29 Mn |
| Sep 30, 2025 | -22.86 Mn |
| Jun 30, 2025 | -51.81 Mn |
| Mar 31, 2025 | -120.88 Mn |
| Dec 31, 2024 | -581,000.00 |
| Sep 30, 2024 | -26.09 Mn |
| Jun 30, 2024 | -30.77 Mn |
| Mar 31, 2024 | -41.68 Mn |
| Dec 31, 2023 | -35.06 Mn |
| Sep 30, 2023 | -31.55 Mn |
| Jun 30, 2023 | -38.81 Mn |
| Mar 31, 2023 | -127.82 Mn |
| Dec 31, 2022 | -17.78 Mn |
| Sep 30, 2022 | -47.49 Mn |
| Jun 30, 2022 | -12.24 Mn |
| Mar 31, 2022 | -15.34 Mn |
| Dec 31, 2021 | 12.74 Mn |
| Sep 30, 2021 | 7.72 Mn |
| Jun 30, 2021 | 5.43 Mn |